title: [Palliative treatment of brain metastases with gamma knife].
abstract: The gamma knife is a stereotactic radiosurgery device which allows well defined, deep seated brain tumors or arteriovenous malformations with a maximal volume of about 25 ccm and a diameter not greater than 3.5 cm, to be treated in a single session under local anesthesia. The gamma knife offers an alternative treatment method to the classical approach of treating brain metastases by surgical excision and/or whole brain radiotherapy. The advantages of this technique are evident: the method is non-invasive, the treatment is carried out in a single session with a very short hospitalisation of two to three days, it is exempt from physical and psychical stress, the head does not need to be shaved and no hair loss occurs, a good quality of life is obtained for a reasonably prolonged survival time and it offers an economically favourable treatment method. Up to December 1999, over 30,000 patients suffering from brain metastases have been treated worldwide using the gamma knife. In Zürich, from September 1994 to December 2000 140 received this treatment. In the literature selection criteria may differ, and this may have determined some of differences in outcome. However, our results are comparable with those in the majority of publications with an average survival time of 263 days and a maximum survival of 1080 days. Good prognostic factors for survival and local control of brain metastases are a Karnofsky Performance Scale Score approaching 90 to 100, but not lower than 70, tumour volume, controlled primary cancer, and absence or stable extracranial metastases.
authors.affiliation: Gamma Knife Zentrum Klinik Im Park Zürich.
authors.forename: J
authors.initials: J
authors.lastname: Siegfried
authors.forename: G
authors.initials: G
authors.lastname: Wellis
authors.forename: S
authors.initials: S
authors.lastname: Scheib
authors.forename: D
authors.initials: D
authors.lastname: Haller
authors.forename: A M
authors.initials: AM
authors.lastname: Landolt
authors.forename: N J
authors.initials: NJ
authors.lastname: Lomax
authors.forename: T
authors.initials: T
authors.lastname: Mindermann
authors.forename: O
authors.initials: O
authors.lastname: Schubiger
authors.forename: W
authors.initials: W
authors.lastname: Wichmann
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000175:diagnosis / Q000556:secondary / Q000601:surgery*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D017567:Karnofsky Performance Status; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010166:Palliative Care / Q000379:methods*; D017410:Practice Guidelines as Topic; D016634:Radiosurgery / Q000379:methods* / Q000706:statistics & numerical data; D012189:Retrospective Studies; D016019:Survival Analysis; D013557:Switzerland
vernacular_title: Palliative Behandlung von Hirnmetastasen mit dem Gamma Knife.